
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : OMTX705
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Oncomatryx
Deal Size : Undisclosed
Deal Type : Collaboration
TFS Expands Partnership with Oncomatryx for OMTX705 Pancreatic Cancer Trial
Details : The collaboration aims to advance the clinical development of OMTX705 in patients with advanced or metastatic pancreatic adenocarcinoma.
Product Name : Undisclosed
Product Type : Antibody-drug Conjugate
Upfront Cash : Undisclosed
May 06, 2025
Lead Product(s) : OMTX705
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Oncomatryx
Deal Size : Undisclosed
Deal Type : Collaboration
